Eligibility to participate
Team participation in Bionics Queensland Challenge 2020 is encouraged from all walks of life. However, team members will typically be drawn from the categories shown below:
- Hospital, university and private sector professionals: Scientists, clinicians, bio-medical engineers, medtech researchers, technology leaders (e.g., AI, data science, machine learning, AR/VR), additive manufacturing experts and allied health professionals.
- Students: Individuals enrolled in medicine, health, bio-medical engineering or allied programs at Queensland universities or in vocational education and training programs. PhD students at metropolitan and regional universities are strongly encouraged to participate.
- Start-ups, Charities, Small Businesses and Grassroots Innovators: The Bionics Challenge is ideally suited to early-stage business ventures, innovative not-for-profit organisations and spinouts from universities or hospitals engaged in innovation.
- Consumers / end users of bionic devices, technologies, products and services – bionics end users and/or carers or family members who are consulted and engaged throughout the project
- Medtech industry leaders and managers: private sector medtech businesses, product designers, technologists, product development and marketing specialists.
All teams should:
- Link people, science and/or technologies that have not been connected before in shaping their bionic innovation
- Proactively engage bionics end users, their carers or family members in the design and development of new or improved bionic devices, implants, technologies and treatments
- Directly involve an industry partner or team member who is a medtech product designer, assistive technology provider and/or manufacturer in the project to help accelerate product or service development and market entry
- Collaborate with intrastate, inter-state and offshore researchers as appropriate to deliver ‘new to the world’ bionic innovations or improve on existing bionic devices, technologies, treatments and services.
Specific Terms and Conditions
1 – Registration and submission of the Pitch to enter Round 1 must be completed online by the published deadline. The criteria sheet for project assessment is published on this website and can be accessed here.
2 – Teams intending to register to enter the National Bionics Innovation Prize and/or a Bionics Challenge ’21 Major Category Prize should read all information and requirementsof the Challenge on our website before registering and submitting their application to enter Round 1 (a brief document outlining the project and team).
3 – All entrants should familiarise themselves with the definition of ‘bionics’ provided online and take due care in choosing which of the four Challenges: (1) Bionic Mobility, (2) Bionic Senses, (3) Bionic Implants and Organs, (4) Neurotech Devices, Brain-Computer-Interfaces and Neurobionic Treatments) is best aligned to their project. Bionics Queensland recognises that the categories are not necessarily mutually exclusive, but one category only should be selected.
4 – Teams from all Australian states and territories are welcome to enter our National Bionics Innovation Prize sponsored by Morgans Financial. Note that the submitted project must align with one of the four categories of bionics innovation outlined in Item 3 above. The winning team may be selected from any one of those categories and will receive $25,000 in cash from Bionics Queensland to be progressively allocated and expended in line with an agreed project plan and milestones (included in a Deed of Grant signed by Bionics Queensland and the recipient).
The winning team will also participate in an agreed Bionics Deeptech Mentoring and Commercialisation Program and receive financial planning advice from Morgans personnel to assist their project going forward.
5 – A minimum of four and a maximum of five team membersis expected in each Challenge team. This rule applies to both Queensland-led teams competing for one of the four Bionics Challenge ’21 Major Category Prizes and to all teams (from Queensland or elsewhere) competing for the National Bionics Innovation Prize.
6 – All teams must include: a nominated project leader with the remaining team members providing an appropriate mix of researchers, clinicians, engineers, technologists and/or practitioners plus a bionics end user (or patient advocate).
- A potential end user (clinician, patient or consumer as appropriate) is a ‘must have’ participant in your team.
- An industry representative is also a necessary inclusion. This individual may be involved in the research, planning, design, fabrication and/or manufacture of your device, implant, technology or treatment.
7 – Industry-based mentors, investment advisors or representatives of other accelerators cannot directly participate in Challenge teams and entrants must be exclusively enrolled in Bionics Queensland ‘21 and no other multi-week accelerator programs for the duration of the Challenge ’21 program (July to mid-November 2021).
This condition recognises the time commitment and level of team interaction needed to succeed and the requirement that all teams complete one of our Bionics Deeptech Mentoring and Commercialisation Training Program options prior to signing and commencing their Deed of Grant with Bionics Queensland for funds dispersal.
8 – Teams competing for the Bionics Challenge 2021 Major Category Prizes ($50,000 per team plus mentoring and acceleration) and Early-Stage Bionics Innovation Awards ($8,000 per team plus mentoring and acceleration) must be Queensland-led.
For the purposes of this Challenge, this means that a project leader living in Queensland must be nominated for the purposes of this project along with at least one other Queensland-based team member. Multi-state, intra-state and international team members are strongly encouraged to optimise the overall expertise, innovation, industry engagement and collaboration brought to the project.
9 – A Queensland-led team may enter one Bionics Challenge ’21 Major Prize Category only but can choose to enter the same project in the competition for the National Bionics Innovation Prize. In this situation, the team must complete two application forms to separately register their participation in their chosen Bionics Challenge ’21 Major Prize Category and the competition for the National Bionics Innovation Prize. Teams should ensure that their project fulfils the specified judging criteria for each prize category.
10 – Early-Stage Bionics Innovation Award winners are selected at the discretion of the judges from teams registered to compete for Bionics Challenge ’21 Major Category prizes. Note that the recipients of this prize may or may not be Challenge finalists, with the primary goal of this award being to support early-stage innovations with the potential to deliver significant impacts in the longer term.
11 – In a situation where an individual researcher/innovator wishes to participate in more than one Challenge team, permission should be formally sought from Bionics Queensland to do so. In this situation, the criticality of that team member’s participation in both teams will be reviewed along with likely impacts of the decision on the viability of both projects.
12 – Team submissions of all materials and presentations required to progress through each Challenge Round must adhere to related guidelines or criteria for each activityprovided on the Challenge website. A failure to do so could disqualify a team.
13 – All Challenge deadlines required for teams to submit materials or attend events must be metin line with the Terms and Conditions stated on this website. This condition applies to all judging rounds in the Challenge and to the team’s participation in our Bionics Deeptech Mentoring and Commercialisation Training Programs.
The Project Leader and one or two other team members must participate in a Bionics Deeptech Mentoring and Commercialisation Training Program (held mid-September to mid-November) and provide relevant input / materials sought. Failure to do so may result in disqualification or a delayed deed of grant for funds dispersal until the condition is met.
14 – The Challenge registration form requires a project title, the name of the Project Leader, the names of all other participants and a list of roles and skill setsthat each team member brings to the project (e.g., patient or bionics end user or their advocate, project leader, bio-medical engineer, software designer, AI specialist, data analyst, device designer, biofabrication specialist, industry representative or other descriptor).
Note: If the team is not fully formed at the time of applying, proposed actions to attract the additional team member(s) and desired skillsets should be outlined. If the existing team/applicant is accepted into the Challenge competition, a complete team (minimum of 4 participants) must exist prior to the Round 1 Pitch event.
15 – The Project Leader of a team must notify the Challenge organiser (Bionics Queensland) of any expected changes or issues that arise with team membershipafter the closing date for entries. Steps must be taken to maintain a minimum of four participants through to and during the staging of the final judging event. Any changes in team members at any point during the Challenge must be approved by Bionics Queensland.
16 – Upon registration, all teams agree that (a) the project leader and team members are willing to participate in events leading up and during the Round 1 Pitch and final judging, and (b) all team members will make themselves available to participate in judging i.e., the Round 1 pitch and final judging event.
Note: All Bionics Challenge ‘21 events, judging rounds and mentoring programs will be delivered in virtual format. Challenge finalists will be offered guidance on final preparation of project plans and slide decks plus video production support services to enable them to successfully prepare their video pitch for the final judging event.
17 – Upon registration, all teams must agree that they have taken steps to identify any existing intellectual property (IP) owned by team members, other individuals or organisations(e.g., an employer, university, hospital or other party) and ensure that any required clearances or agreements are in place. Project leaders should confirm with advisors or legal counsel that any IP included in their public presentations or written submissions is adequately protected. The respective Technology Transfer Offices or Research Offices in organisations linked to the project should be contacted.
Any data or information discussed or divulged in public sessions by entrants should be considered information that could enter the public realm, and entrants should not assume any right of confidentiality in data or information divulged in these sessions. Due to the nature of this Challenge, judges, reviewers, staff or the audience are not obligated and will not be asked to sign non-disclosure statements (NDAs). If a team uses copyrighted materials and/or images from a third party in their submissions or presentations, they must obtain permission in advance and identify the source.
18 – If selected as a Bionics Challenge ’21 prize winner, the project leader and/or IP owner will sign a Deed of Grant with Bionics Queensland that includes:
- Details of how the cash prize will be exclusively used for project expenses aligned to milestone activities and achievements.
- A Challenge funds dispersal timeframe. Funds will be paid on invoice; issued to an ABN, not a person; and must be used to conduct further activities (e.g., industrial design, research, development and/or testing of the innovation) as defined in the Deed of Grant.
- The agreed schedule and timeframe for the team to report to and engage with Bionics Queensland on the progress of the project, the expenditure of funds and the team and/or IP owners’ pathway and model for timely commercialisation of the innovation to benefit populations in need. Note: This Challenge is suited to early to mid-stage innovations versus those that have already received major seed funds.
19 – It is expected that all teams who enter the Challenge will have further research and engagement (e.g., end users, patients or key opinion leaders), clinical testing and prototype development that the cash prize will help to progress. However, scientific research to be completed by teams should not constitute more than 30% of expenditure. Team members are responsible for all tax implications that might arise as a result of accepting cash payments from Bionics Queensland.
20 – All teams are required to participate in media and press opportunities related to the Challenge, including media interviews and statements released to the media in oral and written form. This publicity could occur at any time throughout the Challenge and could feature representatives of Bionics Queensland, the Motor Accident Insurance Commission of Queensland, the Queensland Government and representatives of sponsoring organisations (e.g., Morgans Financial or others) alongside team members.
Challenge team members sign a waiver allowing Bionics Queensland the right to photograph and film their participation during the Challenge events and post-judging publicity campaign for marketing purposes. Participation in media and press opportunities does not require teams to disclose any proprietary or otherwise confidential information related to their business or product concepts.
Bionics Challenge 2021
This years Bionics Challenge, delivered in partnership with the Motor Accident Insurance Commission (Qld) has an overall $300,000 in combined Cash Prizes, Mentoring and Acceleration.
Motor Accident Insurance Commission
The Motor Accident Insurance Commission (MAIC) Queensland is our major funding partner. The rehabilitation of Queenslanders impacted by road accident trauma, disabilities and chronic health conditions underpins our highly valued partnership.